Protein when you're eating less

The Supptide teamPublished Nov 3, 2026 Reviewed Nov 3, 2026

Educational; not medical advice. Supptide doesn't sell peptides and isn't affiliated with any drug maker or peptide seller.

Educational; not medical advice. Supptide isn't affiliated with any drug maker. Last reviewed 27 October 2026.

When you eat less, whether by choice or because a medication has turned down your appetite, the weight you lose isn't all fat. Some of it is lean mass, which includes muscle. How much protein you eat, and whether you train, are the two levers the research points to for keeping more of it.

How much less people eat, and what's lost

People taking GLP-1 medications for weight management (semaglutide; tirzepatide, which also acts on GIP) eat noticeably less. A 2025 joint advisory from four US medical and nutrition societies puts the observed drop in calorie intake at 16% to 39% [1].

In the STEP 1 trial of semaglutide 2.4 mg, average weight change over 68 weeks was −14.9%, against −2.4% on placebo [2]. A body-composition analysis of that trial, summarized in the advisory, found that of an average 13.6 kg lost, 8.3 kg (62%) was fat and 5.3 kg (38%) was lean mass. Muscle is roughly half of lean mass, so about a fifth of the weight lost was muscle [1].

That share varies between studies and measurement methods. Some report lean mass at 15% or less of the weight lost, others at 40% to 60% [3]. It isn't unique to medication either: rapid weight loss of any kind costs some lean tissue [1].

What the protein targets are

  • The general adult recommendation is 0.8 g of protein per kg of body weight a day [1].
  • During active weight reduction, the advisory notes that higher targets of 1.2 to 1.6 g/kg/day have been proposed [1].
  • The limits: intake shouldn't fall below 0.4 to 0.5 g/kg/day, and prolonged intake at or above 2 g/kg/day should be avoided [1].
  • Which body weight? The advisory is candid that it's not settled for people with obesity. Using actual body weight can overestimate needs, and fat-free mass may be the better basis [1].

Two other findings support aiming higher than the minimum:

  • In a meta-analysis of 20 trials in adults over 50 who were losing weight on purpose, those on higher-protein diets kept more lean mass and lost more fat [4].
  • In a meta-analysis of 49 trials in healthy adults doing resistance training, extra protein added a small amount of strength and lean mass. Gains in lean mass stopped increasing above a total intake of about 1.6 g/kg/day [5].

Per meal, not just per day

How protein is spread across the day matters for muscle building. In young men after leg exercise, muscle protein synthesis rose with protein doses up to about 20 g per serving and then levelled off, whether the protein was egg [6] or whey [7]. Eating less overall makes it harder to reach that at every meal, so it helps to plan protein first.

Training is the other half

Protein is the raw material, but resistance training is the signal. The advisory recommends strength training at least three times a week plus at least 150 minutes of moderate aerobic activity to help preserve muscle and bone [1].

In one randomized trial, people kept off weight for a year with a GLP-1 medication (liraglutide), exercise, both, or neither. Those on the medication alone lost more bone density at the hip and spine than those who exercised. Combining the two preserved it [8].

Practical takeaways

  • Work out a protein target with your clinician or dietitian. The 1.2 to 1.6 g/kg/day range proposed during active weight reduction is a starting point for that conversation.
  • Put protein first at each meal. Smaller appetites fill up fast.
  • Spread it out, roughly 20 g or more at each main meal.
  • Lift weights at least three times a week if you can.
  • If you take a prescription medication, check any big diet change with your prescriber.

What we don't know yet

  • The best protein target specifically for people on GLP-1 medications hasn't been tested in its own trials. The targets above come from weight-loss and training research more broadly [1].
  • How much of the lean mass lost is muscle, and whether it affects strength, is still debated. One review argues the muscle changes are roughly what weight loss and age would predict [3].

References

  1. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122:344-367. doi:10.1016/j.ajcnut.2025.04.023
  2. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989-1002. doi:10.1056/NEJMoa2032183
  3. Neeland IJ, et al. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26(Suppl 4):16-27. doi:10.1111/dom.15728
  4. Kim JE, et al. Effects of dietary protein intake on body composition changes after weight loss in older adults: a systematic review and meta-analysis. Nutr Rev. 2016;74:210-224. doi:10.1093/nutrit/nuv065
  5. Morton RW, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52:376-384. doi:10.1136/bjsports-2017-097608
  6. Moore DR, et al. Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. Am J Clin Nutr. 2009;89:161-168. doi:10.3945/ajcn.2008.26401
  7. Witard OC, et al. Myofibrillar muscle protein synthesis rates subsequent to a meal in response to increasing doses of whey protein at rest and after resistance exercise. Am J Clin Nutr. 2014;99:86-95. doi:10.3945/ajcn.112.055517
  8. Jensen SBK, et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2024;7:e2416775. doi:10.1001/jamanetworkopen.2024.16775

This is a summary of other people's research; it isn't our study, and no Supptide product was studied in it. Educational; not medical advice.